Tocilizumab for Acute Chest Syndrome

Clinical trial NCT05640271 · RECRUITING

Trial details

NCT number: NCT05640271
Sponsor: University of Chicago
Status: RECRUITING
Phase: Phase 2
Study type: INTERVENTIONAL

Sickle Cell Disease Acute Chest Syndrome

Start date: 2023-04-10
Primary completion: 2026-10-01
Enrollment: 200

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.